REMED Overview
- Year Founded
-
2003
- Status
-
Public
- Employees
-
107
- Stock Symbol
-
302550
- Investments
-
1
- Share Price
-
$1.96
- (As of Wednesday Closing)
REMED General Information
Description
Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.
Contact Information
Website
www.remed.krCorporate Office
- 21-7, Wiryeseo-1-gil
- Sujeong-gu
- Seongnam, Gyeonggi 13647
- South Korea
Corporate Office
- 21-7, Wiryeseo-1-gil
- Sujeong-gu
- Seongnam, Gyeonggi 13647
- South Korea
REMED Stock Performance
As of 18-Nov-2026, REMED’s stock price is $1.96. Its current market cap is $58M with 29.5M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.96 | $1.94 | $1.49 - $2.82 | $58M | 29.5M | 442K | $0.05 |
REMED Financials Summary
As of 30-Sep-2026, REMED has a trailing 12-month revenue of $19.8M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 53,723 | 58,113 | 72,698 | 79,743 |
| Revenue | 19,807 | 17,219 | 18,729 | 14,177 |
| EBITDA | 2,522 | 1,202 | 7,368 | 1,783 |
| Net Income | 1,449 | 370 | 5,256 | 610 |
| Total Assets | 39,476 | 37,437 | 40,098 | 42,726 |
| Total Debt | 4,421 | 3,773 | 5,278 | 12,949 |
REMED Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
REMED Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
REMED Patents
REMED Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023177040-A1 | Magnetic field-generating therapeutic device having plurality of cooling structures | Inactive | 14-Mar-2022 | ||
| US-20230285767-A1 | Treatment device using magnetic field | Pending | 14-Mar-2022 | ||
| WO-2023080310-A1 | Air-cooled magnetic stimulator | Inactive | 03-Nov-2021 | ||
| WO-2023054804-A1 | Magnetic stimulation device comprising two or more applicators | Inactive | 30-Sep-2021 | ||
| JP-7510729-B2 | Magnetic field stimulation device | Active | 23-Oct-2020 | A61N2/02 |
REMED Signals
REMED Investments (1)
REMED’s most recent deal was a Corporate Asset Purchase with Jaeseong Jeong (Office Building in Seongnam, South Korea) for . The deal was made on 22-Jul-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jaeseong Jeong (Office Building in Seongnam, South Korea) | 22-Jul-2020 | Corporate Asset Purchase | Buildings and Property |
REMED ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
REMED Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Remed Japan | Chuo-ku, Japan | 2023 |
REMED FAQs
-
When was REMED founded?
REMED was founded in 2003.
-
Where is REMED headquartered?
REMED is headquartered in Seongnam, South Korea.
-
What is the size of REMED?
REMED has 107 total employees.
-
What industry is REMED in?
REMED’s primary industry is Therapeutic Devices.
-
Is REMED a private or public company?
REMED is a Public company.
-
What is REMED’s stock symbol?
The ticker symbol for REMED is 302550.
-
What is the current stock price of REMED?
As of 18-Nov-2026 the stock price of REMED is $1.96.
-
What is the current market cap of REMED?
The current market capitalization of REMED is $58M.
-
What is REMED’s current revenue?
The trailing twelve month revenue for REMED is $19.8M.
-
What is REMED’s annual earnings per share (EPS)?
REMED’s EPS for 12 months was $0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process